Pharmaceutical products in Libya are regulated by the Libyan Ministry of Health and the Libyan National Center for Food and Drug Control (NCFDC). The regulatory framework focuses on ensuring medicine quality, preventing counterfeit products, and strengthening oversight of pharmaceutical imports and distribution.
Libya has introduced initiatives to improve medicine authentication and supply chain monitoring, including the use of barcode based product identification on pharmaceutical packaging. These measures are intended to support verification of medicines distributed within the country and improve regulatory monitoring.
However, Libya does not currently operate a fully implemented national pharmaceutical serialization or track and trace system. Regulatory oversight relies primarily on medicine registration, import control, and inspection of distribution channels.
Pharmaceutical companies supplying medicines to Libya should monitor regulatory developments, as authorities have expressed interest in expanding digital traceability mechanisms in the future.